初次全膝关节置换术后高危与标准风险患者延长口服抗生素预防的使用率:2009年至2022年
该研究基于美国国家保险理赔数据库,分析了2009至2022年间712,212例初次全膝关节置换术(TKA)患者,发现延长口服抗生素(EOA)预防使用率从2009年的0.91%上升至2022年的7.95%,标准风险患者上升686%,高风险患者上升786%,患者合并症变化无法解释此趋势,预测2030年将升至18.3%。
要点
- 初次TKA后EOA预防使用率从2009年0.91%升至2022年7.95%。
- 标准风险患者EOA使用率增加686%,高风险患者增加786%。
- 患者合并症变化无法解释EOA使用率的上升趋势。
核心结论
- 初次TKA后EOA预防使用率在2009至2022年间显著上升,该趋势无法由患者特征变化解释,提示抗生素处方实践普遍改变,可能反映了近期支持EOA使用的研究。
研究设计与样本
- 研究基于国家保险理赔数据库识别2009年至2022年间接受TKA的成年患者,共纳入712,212例合格TKA病例,采用多变量逻辑回归和时间序列预测进行分析。
主要发现
- EOA使用率从2009年的0.91%上升至2022年的7.95%。
- 标准风险患者EOA使用率增加686%,高风险患者增加786%。
- 使用患者合并症的逻辑回归模型无法解释EOA使用率的变化。
- 预测EOA使用率到2030年将上升至18.3%。
关键数值与推荐
- EOA定义为术前5天至术后3天期间开具的7至14天疗程的第一代头孢菌素、头孢地尼、克林霉素、多西环素或甲氧苄啶-磺胺甲噁唑。
- 按术前假体周围感染风险对年度EOA使用率进行分层。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步高质量研究检验EOA预防在初次TKA患者群体中的安全性、有效性和作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent evidence suggests extended courses of oral antibiotics (EOA) after total hip arthroplasty and total knee arthroplasty (TKA) may reduce the risk of periprosthetic joint infection in high-risk patients. EOA rates after total hip arthroplasty have risen significantly. However, there is a lack of epidemiologic data on EOA prophylaxis following TKA. Therefore, we investigated national trends in EOA prophylaxis for primary TKA and whether these rates were reflective of changes in patient risk or prescribing practices. METHODS: Adult patients undergoing TKA between 2009 and 2022 were identified in a national insurance claims database. An EOA was defined as a 7 to 14-day course of a first-generation cephalosporin, cefdinir, clindamycin, doxycycline, or trimethoprim-sulfamethoxazole filled between 5 days preoperatively and 3 days postoperatively. Annual EOA rates were calculated and stratified by preoperative periprosthetic joint infection risk. Multivariable logistic regression was used to explore whether rates reflected changing patient characteristics. Future rates were predicted with time-series forecasting. RESULTS: We identified 712,212 eligible TKA cases. EOA rates rose from 0.91% in 2009 to 7.95% in 2022. Rates increased by 686% among standard-risk patients and 786% among high-risk patients. Logistic regression models using patient comorbidities could not account for changes in EOA rates. EOA rates were projected to rise to 18.3% by 2030. CONCLUSIONS: Rates of EOA prophylaxis after TKA rose significantly from 2009 to 2022. This trend could not be explained by changing patient characteristics, suggesting widespread changes in antibiotic prescribing practices, which may be reflective of recent studies favoring EOA use. There is a need for further high-quality research examining the safety, efficacy, and role of EOA prophylaxis in the primary TKA patient population.
引用
- Pisharody VA, Fuqua A, Ayeni A, et al. Rates of Extended Oral Antibiotic Prophylaxis After Primary Total Knee Arthroplasty Among High-Risk and Standard-Risk Patients: 2009 to 2022. J Arthroplasty. 2024. PMID: 39551410. doi:10.1016/j.arth.2024.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。